JP2009249366A - Collagen production promotor and anti-aging skin preparation for external use - Google Patents
Collagen production promotor and anti-aging skin preparation for external use Download PDFInfo
- Publication number
- JP2009249366A JP2009249366A JP2008102314A JP2008102314A JP2009249366A JP 2009249366 A JP2009249366 A JP 2009249366A JP 2008102314 A JP2008102314 A JP 2008102314A JP 2008102314 A JP2008102314 A JP 2008102314A JP 2009249366 A JP2009249366 A JP 2009249366A
- Authority
- JP
- Japan
- Prior art keywords
- extract
- collagen production
- skin
- prepared
- collagen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000037319 collagen production Effects 0.000 title claims abstract description 36
- 238000002360 preparation method Methods 0.000 title claims abstract description 34
- 230000003712 anti-aging effect Effects 0.000 title claims abstract description 13
- 239000000284 extract Substances 0.000 claims abstract description 105
- 239000004480 active ingredient Substances 0.000 claims abstract description 12
- 241000208838 Asteraceae Species 0.000 claims abstract description 8
- 235000015471 Pluchea indica Nutrition 0.000 claims abstract description 4
- 244000118351 Pluchea indica Species 0.000 claims abstract description 4
- 210000003491 skin Anatomy 0.000 description 41
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 23
- 102000008186 Collagen Human genes 0.000 description 19
- 108010035532 Collagen Proteins 0.000 description 19
- -1 For example Substances 0.000 description 19
- 229920001436 collagen Polymers 0.000 description 19
- 239000006071 cream Substances 0.000 description 19
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 18
- 244000260524 Chrysanthemum balsamita Species 0.000 description 18
- 235000005633 Chrysanthemum balsamita Nutrition 0.000 description 18
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 18
- 239000000203 mixture Substances 0.000 description 17
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 17
- 239000006210 lotion Substances 0.000 description 15
- 238000000034 method Methods 0.000 description 15
- 210000004027 cell Anatomy 0.000 description 13
- 238000010438 heat treatment Methods 0.000 description 13
- 238000004519 manufacturing process Methods 0.000 description 13
- 239000004615 ingredient Substances 0.000 description 12
- 239000002609 medium Substances 0.000 description 12
- 239000008213 purified water Substances 0.000 description 12
- 235000019441 ethanol Nutrition 0.000 description 11
- 235000011187 glycerol Nutrition 0.000 description 11
- 230000001737 promoting effect Effects 0.000 description 11
- 210000002950 fibroblast Anatomy 0.000 description 10
- 229940058015 1,3-butylene glycol Drugs 0.000 description 9
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 9
- 235000019437 butane-1,3-diol Nutrition 0.000 description 9
- 239000003795 chemical substances by application Substances 0.000 description 9
- 239000002304 perfume Substances 0.000 description 9
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 8
- 239000003755 preservative agent Substances 0.000 description 8
- 230000002335 preservative effect Effects 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 7
- 239000000839 emulsion Substances 0.000 description 7
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 210000004207 dermis Anatomy 0.000 description 6
- 238000000605 extraction Methods 0.000 description 6
- 239000000523 sample Substances 0.000 description 6
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 6
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 5
- 235000021355 Stearic acid Nutrition 0.000 description 5
- 239000012190 activator Substances 0.000 description 5
- 230000007423 decrease Effects 0.000 description 5
- 239000003974 emollient agent Substances 0.000 description 5
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 5
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 5
- 239000000843 powder Substances 0.000 description 5
- 239000008117 stearic acid Substances 0.000 description 5
- CUNWUEBNSZSNRX-RKGWDQTMSA-N (2r,3r,4r,5s)-hexane-1,2,3,4,5,6-hexol;(z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O CUNWUEBNSZSNRX-RKGWDQTMSA-N 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 4
- 229920002125 Sokalan® Polymers 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- 235000014113 dietary fatty acids Nutrition 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 239000000194 fatty acid Substances 0.000 description 4
- 229930195729 fatty acid Natural products 0.000 description 4
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 4
- 229940075507 glyceryl monostearate Drugs 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 229940057995 liquid paraffin Drugs 0.000 description 4
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 4
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 4
- 229920001296 polysiloxane Polymers 0.000 description 4
- 210000002966 serum Anatomy 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 229960005078 sorbitan sesquioleate Drugs 0.000 description 4
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 3
- FLPJVCMIKUWSDR-UHFFFAOYSA-N 2-(4-formylphenoxy)acetamide Chemical compound NC(=O)COC1=CC=C(C=O)C=C1 FLPJVCMIKUWSDR-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 3
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 229940074979 cetyl palmitate Drugs 0.000 description 3
- 238000012937 correction Methods 0.000 description 3
- 239000002537 cosmetic Substances 0.000 description 3
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 3
- 239000003205 fragrance Substances 0.000 description 3
- PXDJXZJSCPSGGI-UHFFFAOYSA-N hexadecanoic acid hexadecyl ester Natural products CCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC PXDJXZJSCPSGGI-UHFFFAOYSA-N 0.000 description 3
- 229940119170 jojoba wax Drugs 0.000 description 3
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 235000019198 oils Nutrition 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 238000007665 sagging Methods 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 230000009759 skin aging Effects 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 229940032094 squalane Drugs 0.000 description 3
- 229940099259 vaseline Drugs 0.000 description 3
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 2
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 2
- 235000005254 Allium ampeloprasum Nutrition 0.000 description 2
- 240000006108 Allium ampeloprasum Species 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 2
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 2
- DATAGRPVKZEWHA-YFKPBYRVSA-N N(5)-ethyl-L-glutamine Chemical compound CCNC(=O)CC[C@H]([NH3+])C([O-])=O DATAGRPVKZEWHA-YFKPBYRVSA-N 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 229940123973 Oxygen scavenger Drugs 0.000 description 2
- 235000019482 Palm oil Nutrition 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- 230000006750 UV protection Effects 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 125000000217 alkyl group Chemical group 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 229940121363 anti-inflammatory agent Drugs 0.000 description 2
- 239000002260 anti-inflammatory agent Substances 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 235000013871 bee wax Nutrition 0.000 description 2
- 239000012166 beeswax Substances 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 239000007844 bleaching agent Substances 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- 238000004364 calculation method Methods 0.000 description 2
- 244000309466 calf Species 0.000 description 2
- 239000004359 castor oil Substances 0.000 description 2
- 235000019438 castor oil Nutrition 0.000 description 2
- 229960000541 cetyl alcohol Drugs 0.000 description 2
- 235000020221 chamomile extract Nutrition 0.000 description 2
- 235000015165 citric acid Nutrition 0.000 description 2
- 239000007857 degradation product Substances 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 230000002349 favourable effect Effects 0.000 description 2
- 238000000855 fermentation Methods 0.000 description 2
- 230000004151 fermentation Effects 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 2
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 2
- 239000001685 glycyrrhizic acid Substances 0.000 description 2
- 229960004949 glycyrrhizic acid Drugs 0.000 description 2
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 2
- 235000019410 glycyrrhizin Nutrition 0.000 description 2
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000003906 humectant Substances 0.000 description 2
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 230000007721 medicinal effect Effects 0.000 description 2
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 2
- 239000002540 palm oil Substances 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 229940093430 polyethylene glycol 1500 Drugs 0.000 description 2
- 235000013772 propylene glycol Nutrition 0.000 description 2
- 239000011814 protection agent Substances 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 239000012488 sample solution Substances 0.000 description 2
- 239000000344 soap Substances 0.000 description 2
- 229940045920 sodium pyrrolidone carboxylate Drugs 0.000 description 2
- HYRLWUFWDYFEES-UHFFFAOYSA-M sodium;2-oxopyrrolidine-1-carboxylate Chemical compound [Na+].[O-]C(=O)N1CCCC1=O HYRLWUFWDYFEES-UHFFFAOYSA-M 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 2
- 150000005846 sugar alcohols Polymers 0.000 description 2
- 239000012085 test solution Substances 0.000 description 2
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
- CMCBDXRRFKYBDG-UHFFFAOYSA-N 1-dodecoxydodecane Chemical compound CCCCCCCCCCCCOCCCCCCCCCCCC CMCBDXRRFKYBDG-UHFFFAOYSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- GLXBPZNFNSLJBS-UHFFFAOYSA-N 11-methyldodecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCCCCCCCCCCC(C)C GLXBPZNFNSLJBS-UHFFFAOYSA-N 0.000 description 1
- SPSPIUSUWPLVKD-UHFFFAOYSA-N 2,3-dibutyl-6-methylphenol Chemical compound CCCCC1=CC=C(C)C(O)=C1CCCC SPSPIUSUWPLVKD-UHFFFAOYSA-N 0.000 description 1
- TWJNQYPJQDRXPH-UHFFFAOYSA-N 2-cyanobenzohydrazide Chemical compound NNC(=O)C1=CC=CC=C1C#N TWJNQYPJQDRXPH-UHFFFAOYSA-N 0.000 description 1
- HIPQTCQUXOFTFI-UHFFFAOYSA-N 2-methoxy-1,3-diphenylpropane-1,3-dione Chemical compound C=1C=CC=CC=1C(=O)C(OC)C(=O)C1=CC=CC=C1 HIPQTCQUXOFTFI-UHFFFAOYSA-N 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 1
- IJALWSVNUBBQRA-UHFFFAOYSA-N 4-Isopropyl-3-methylphenol Chemical compound CC(C)C1=CC=C(O)C=C1C IJALWSVNUBBQRA-UHFFFAOYSA-N 0.000 description 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- 235000017060 Arachis glabrata Nutrition 0.000 description 1
- 244000105624 Arachis hypogaea Species 0.000 description 1
- 235000010777 Arachis hypogaea Nutrition 0.000 description 1
- 235000018262 Arachis monticola Nutrition 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Natural products OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 235000018185 Betula X alpestris Nutrition 0.000 description 1
- 235000018212 Betula X uliginosa Nutrition 0.000 description 1
- 241000186000 Bifidobacterium Species 0.000 description 1
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 1
- 241001474374 Blennius Species 0.000 description 1
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 description 1
- 241000252229 Carassius auratus Species 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- 240000008067 Cucumis sativus Species 0.000 description 1
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 1
- 239000011703 D-panthenol Substances 0.000 description 1
- 235000004866 D-panthenol Nutrition 0.000 description 1
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- AFSDNFLWKVMVRB-UHFFFAOYSA-N Ellagic acid Chemical compound OC1=C(O)C(OC2=O)=C3C4=C2C=C(O)C(O)=C4OC(=O)C3=C1 AFSDNFLWKVMVRB-UHFFFAOYSA-N 0.000 description 1
- ATJXMQHAMYVHRX-CPCISQLKSA-N Ellagic acid Natural products OC1=C(O)[C@H]2OC(=O)c3cc(O)c(O)c4OC(=O)C(=C1)[C@H]2c34 ATJXMQHAMYVHRX-CPCISQLKSA-N 0.000 description 1
- 229920002079 Ellagic acid Polymers 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- FPVVYTCTZKCSOJ-UHFFFAOYSA-N Ethylene glycol distearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCOC(=O)CCCCCCCCCCCCCCCCC FPVVYTCTZKCSOJ-UHFFFAOYSA-N 0.000 description 1
- 235000009419 Fagopyrum esculentum Nutrition 0.000 description 1
- 240000008620 Fagopyrum esculentum Species 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 241001071795 Gentiana Species 0.000 description 1
- 239000009429 Ginkgo biloba extract Substances 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 1
- 241001316290 Gypsophila Species 0.000 description 1
- 241000208690 Hamamelis Species 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- 235000013719 Houttuynia cordata Nutrition 0.000 description 1
- 240000000691 Houttuynia cordata Species 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 241000546188 Hypericum Species 0.000 description 1
- 235000017309 Hypericum perforatum Nutrition 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- 102000010445 Lactoferrin Human genes 0.000 description 1
- 108010063045 Lactoferrin Proteins 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- 238000000134 MTT assay Methods 0.000 description 1
- 231100000002 MTT assay Toxicity 0.000 description 1
- 240000000982 Malva neglecta Species 0.000 description 1
- 235000000060 Malva neglecta Nutrition 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 235000021360 Myristic acid Nutrition 0.000 description 1
- TUNFSRHWOTWDNC-UHFFFAOYSA-N Myristic acid Natural products CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 1
- SUZRRICLUFMAQD-UHFFFAOYSA-N N-Methyltaurine Chemical compound CNCCS(O)(=O)=O SUZRRICLUFMAQD-UHFFFAOYSA-N 0.000 description 1
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 description 1
- 235000017879 Nasturtium officinale Nutrition 0.000 description 1
- 240000005407 Nasturtium officinale Species 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 235000006484 Paeonia officinalis Nutrition 0.000 description 1
- 244000170916 Paeonia officinalis Species 0.000 description 1
- 235000004347 Perilla Nutrition 0.000 description 1
- 244000124853 Perilla frutescens Species 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- 239000009724 Salvia extract Substances 0.000 description 1
- 240000000513 Santalum album Species 0.000 description 1
- 235000008632 Santalum album Nutrition 0.000 description 1
- 235000002953 Saxifraga stolonifera Nutrition 0.000 description 1
- 244000288377 Saxifraga stolonifera Species 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 102000019197 Superoxide Dismutase Human genes 0.000 description 1
- 108010012715 Superoxide dismutase Proteins 0.000 description 1
- 235000005865 Symphytum officinale Nutrition 0.000 description 1
- 240000002299 Symphytum officinale Species 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 102000003425 Tyrosinase Human genes 0.000 description 1
- 108060008724 Tyrosinase Proteins 0.000 description 1
- 244000274883 Urtica dioica Species 0.000 description 1
- 235000009108 Urtica dioica Nutrition 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 229960000271 arbutin Drugs 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 235000009697 arginine Nutrition 0.000 description 1
- 229940089116 arnica extract Drugs 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 239000003212 astringent agent Substances 0.000 description 1
- 229940069780 barley extract Drugs 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 1
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 229940008396 carrot extract Drugs 0.000 description 1
- 235000005487 catechin Nutrition 0.000 description 1
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 1
- 239000006143 cell culture medium Substances 0.000 description 1
- 229940106189 ceramide Drugs 0.000 description 1
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 description 1
- 229940119217 chamomile extract Drugs 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- 229950001002 cianidanol Drugs 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 238000004042 decolorization Methods 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 239000002781 deodorant agent Substances 0.000 description 1
- 238000004332 deodorization Methods 0.000 description 1
- 229960003949 dexpanthenol Drugs 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 229940105990 diglycerin Drugs 0.000 description 1
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 229960002852 ellagic acid Drugs 0.000 description 1
- 235000004132 ellagic acid Nutrition 0.000 description 1
- 229960003720 enoxolone Drugs 0.000 description 1
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- MJEMIOXXNCZZFK-UHFFFAOYSA-N ethylone Chemical compound CCNC(C)C(=O)C1=CC=C2OCOC2=C1 MJEMIOXXNCZZFK-UHFFFAOYSA-N 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 239000012737 fresh medium Substances 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000003349 gelling agent Substances 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 229940002508 ginger extract Drugs 0.000 description 1
- 235000020708 ginger extract Nutrition 0.000 description 1
- 235000020686 ginkgo biloba extract Nutrition 0.000 description 1
- 229940068052 ginkgo biloba extract Drugs 0.000 description 1
- 235000020710 ginseng extract Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 229940038487 grape extract Drugs 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 235000020717 hawthorn extract Nutrition 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- WTFXARWRTYJXII-UHFFFAOYSA-N iron(2+);iron(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[O-2].[Fe+2].[Fe+3].[Fe+3] WTFXARWRTYJXII-UHFFFAOYSA-N 0.000 description 1
- SZVJSHCCFOBDDC-UHFFFAOYSA-N iron(II,III) oxide Inorganic materials O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 description 1
- NFIDBGJMFKNGGQ-UHFFFAOYSA-N isopropylmethylphenol Natural products CC(C)CC1=CC=CC=C1O NFIDBGJMFKNGGQ-UHFFFAOYSA-N 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- 239000003410 keratolytic agent Substances 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- TYQCGQRIZGCHNB-JLAZNSOCSA-N l-ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(O)=C(O)C1=O TYQCGQRIZGCHNB-JLAZNSOCSA-N 0.000 description 1
- CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 description 1
- 229940078795 lactoferrin Drugs 0.000 description 1
- 235000021242 lactoferrin Nutrition 0.000 description 1
- 229940069445 licorice extract Drugs 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 229940074358 magnesium ascorbate Drugs 0.000 description 1
- AIOKQVJVNPDJKA-ZZMNMWMASA-L magnesium;(2r)-2-[(1s)-1,2-dihydroxyethyl]-4-hydroxy-5-oxo-2h-furan-3-olate Chemical compound [Mg+2].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] AIOKQVJVNPDJKA-ZZMNMWMASA-L 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 229960001855 mannitol Drugs 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- FAARLWTXUUQFSN-UHFFFAOYSA-N methylellagic acid Natural products O1C(=O)C2=CC(O)=C(O)C3=C2C2=C1C(OC)=C(O)C=C2C(=O)O3 FAARLWTXUUQFSN-UHFFFAOYSA-N 0.000 description 1
- 239000010445 mica Substances 0.000 description 1
- 229910052618 mica group Inorganic materials 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 235000013379 molasses Nutrition 0.000 description 1
- VMGAPWLDMVPYIA-HIDZBRGKSA-N n'-amino-n-iminomethanimidamide Chemical compound N\N=C\N=N VMGAPWLDMVPYIA-HIDZBRGKSA-N 0.000 description 1
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- HMMGMWAXVFQUOA-UHFFFAOYSA-N octamethylcyclotetrasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 HMMGMWAXVFQUOA-UHFFFAOYSA-N 0.000 description 1
- DXGLGDHPHMLXJC-UHFFFAOYSA-N oxybenzone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 DXGLGDHPHMLXJC-UHFFFAOYSA-N 0.000 description 1
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 235000020232 peanut Nutrition 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229940093429 polyethylene glycol 6000 Drugs 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 238000007781 pre-processing Methods 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 235000008160 pyridoxine Nutrition 0.000 description 1
- 239000011677 pyridoxine Substances 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 1
- 229940069774 quince extract Drugs 0.000 description 1
- BOLDJAUMGUJJKM-LSDHHAIUSA-N renifolin D Natural products CC(=C)[C@@H]1Cc2c(O)c(O)ccc2[C@H]1CC(=O)c3ccc(O)cc3O BOLDJAUMGUJJKM-LSDHHAIUSA-N 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011607 retinol Substances 0.000 description 1
- 229960003471 retinol Drugs 0.000 description 1
- 235000020944 retinol Nutrition 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 235000020748 rosemary extract Nutrition 0.000 description 1
- 229940109850 royal jelly Drugs 0.000 description 1
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 1
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 1
- 235000005493 rutin Nutrition 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 235000004400 serine Nutrition 0.000 description 1
- 230000037393 skin firmness Effects 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 239000001540 sodium lactate Substances 0.000 description 1
- 229940005581 sodium lactate Drugs 0.000 description 1
- 235000011088 sodium lactate Nutrition 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 239000001587 sorbitan monostearate Substances 0.000 description 1
- 235000011076 sorbitan monostearate Nutrition 0.000 description 1
- 229940035048 sorbitan monostearate Drugs 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 238000009331 sowing Methods 0.000 description 1
- 235000020712 soy bean extract Nutrition 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000001384 succinic acid Substances 0.000 description 1
- 235000011044 succinic acid Nutrition 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 229940026510 theanine Drugs 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- GYDJEQRTZSCIOI-LJGSYFOKSA-N tranexamic acid Chemical compound NC[C@H]1CC[C@H](C(O)=O)CC1 GYDJEQRTZSCIOI-LJGSYFOKSA-N 0.000 description 1
- 229960000401 tranexamic acid Drugs 0.000 description 1
- QPQANCNBWQXGTQ-UHFFFAOYSA-N trihydroxy(trimethylsilylperoxy)silane Chemical compound C[Si](C)(C)OO[Si](O)(O)O QPQANCNBWQXGTQ-UHFFFAOYSA-N 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 229920003169 water-soluble polymer Polymers 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Landscapes
- Cosmetics (AREA)
Abstract
Description
本発明は新規なコラーゲン産生促進剤、及び当該促進剤を有効成分として含有する老化防止用皮膚外用剤に関する。 The present invention relates to a novel collagen production promoter and an anti-aging skin external preparation containing the promoter as an active ingredient.
皮膚の老化の原因は様々あるが、その一つとして真皮内のコラーゲン量の低下、及びコラーゲンそのものが変性して機能低下するなどが挙げられる。コラーゲンは、皮膚の深層の真皮を構成し、皮膚にハリを与え、たるみなどを抑制する作用があるが、加齢や紫外線照射により、体内におけるコラーゲンの産生能が低下したり、コラーゲンそのものが変性し機能が低下したりし、皮膚にハリがなくなり、しわやたるみが発生して、外観上、皮膚老化として認識される。コラーゲンは、真皮内に存在する線維芽細胞によって産生されるので、この線維芽細胞を賦活化させる剤、例えば、アスコルビン酸リン酸マグネシウム(VC−PMg)などが、老化防止用皮膚外用剤の有効成分として従来利用されている。しかし、市場のより高い要求に応えるためには、より優れたコラーゲン産生促進作用を示す新規な剤の提供が望まれる。 There are various causes of skin aging, and one of them is a decrease in the amount of collagen in the dermis and a decrease in function due to degeneration of the collagen itself. Collagen constitutes the deep dermis of the skin and has the action of giving the skin firmness and suppressing sagging, etc., but the ability to produce collagen in the body decreases due to aging and ultraviolet irradiation, or the collagen itself is denatured The function is reduced, the skin is not firm, wrinkles and sagging occur, and it is recognized as skin aging in appearance. Since collagen is produced by fibroblasts present in the dermis, agents that activate the fibroblasts, such as magnesium ascorbate phosphate (VC-PMg), are effective as an anti-aging skin external preparation. Conventionally used as an ingredient. However, in order to meet the higher demands of the market, it is desired to provide a novel agent exhibiting a superior collagen production promoting action.
一方、皮膚外用剤は皮膚に直接塗布されることから、有効成分として用いられる薬効剤には高い安全性が求められる。そのため、従来、種々の植物抽出物について、その薬効が検討されている。キク科ヒヒラギギク(学名:Pluchea indica Less)については、チロシナーゼ阻害作用等があることが報告されているが(特許文献1〜4)、線維芽細胞に対する賦活作用、及びコラーゲン産生促進作用については、従来知られていない。
本発明は、安全性が良好な新規なコラーゲン産生促進剤、及び当該促進剤を有効成分として含有する老化防止用皮膚外用剤を提供することを課題とする。 An object of the present invention is to provide a novel collagen production promoter having good safety, and an anti-aging skin external preparation containing the promoter as an active ingredient.
本発明者が鋭意検討した結果、キク科ヒヒラギギクの抽出物には線維芽細胞に対する高い賦活作用があること、さらにそれによって優れたコラーゲン産生促進作用を示すこと、さらにはそのコラーゲン産生促進作用は、皮膚外用剤に配合しても有効に発揮されることを見出し、この知見に基づいて、本発明を完成するに至った。
即ち、本発明は、前記課題を解決するため、キク科ヒヒラギギクの抽出物を有効成分とするコラーゲン産生促進剤、及び当該コラーゲン産生促進剤を有効成分として含有する老化防止用皮膚外用剤を提供する。
また、別の観点から、本発明によって、キク科ヒヒラギギクの抽出物を皮膚に塗布することによって、真皮内におけるコラーゲン産生を促進する方法(但し、人間の治療方法は除く)が提供される。
As a result of intensive studies by the present inventor, the extract of Asteraceae laevis has a high activation effect on fibroblasts, and further exhibits an excellent collagen production promoting action, and further, the collagen production promoting action is It has been found that even when blended with an external preparation for skin, it can be effectively exhibited, and based on this finding, the present invention has been completed.
That is, the present invention provides a collagen production promoter containing an extract of Asteraceae daisies as an active ingredient and an anti-aging skin external preparation containing the collagen production promoter as an active ingredient in order to solve the above-mentioned problems. .
From another point of view, according to the present invention, there is provided a method of promoting collagen production in the dermis by applying an extract of Asteraceae daisies to the skin (except for a method for human treatment).
本発明によれば、安全性が良好な新規なコラーゲン産生促進剤、及び当該促進剤を有効成分として含有する老化防止用皮膚外用剤を提供することができる。 ADVANTAGE OF THE INVENTION According to this invention, the novel collagen production promoter with favorable safety | security and the skin external preparation for anti-aging which contains the said promoter as an active ingredient can be provided.
以下、本発明について詳細に説明する。なお、本明細書において、「〜」はその前後の数値を含む範囲を意味するものとする。
本発明は、キク科ヒヒラギギクの抽出物(以下、「ヒヒラギギク抽出物」という場合がある)を有効成分とするコラーゲン産生促進剤に関する。キク科ヒヒラギギクは、ベランタス(Belantas)と呼ばれる、学名Pluchea indica Lessの植物であり、ジャワ島などに生息し、また食用に栽培もされている。
Hereinafter, the present invention will be described in detail. In the present specification, “to” means a range including numerical values before and after.
TECHNICAL FIELD The present invention relates to a collagen production promoter comprising an extract of Asteraceae daisies (hereinafter sometimes referred to as “a daisies extract”) as an active ingredient. Asteraceae, Hilatagiku, is a plant of the scientific name Pluchea indica Less, called Belantas, inhabiting Java Island and cultivated for food.
本発明に用いられるヒヒラギギク抽出物は、一般的な方法で調製することができる。例えば、ヒヒラギギクの根、茎、幹、葉、花等のいずれの部分の抽出物であってもよいし、二箇所以上の部分から得られた抽出物を混合して用いてもよく、又は二箇所以上の部分から異なる溶媒により抽出された抽出物を二種以上混合して用いてもよい。抽出溶媒としては特に限定されないが、例えば、水;メチルアルコール、エチルアルコール等の低級一価アルコール;グリセリン、プロピレングリコール、1,3−ブチレングリコール等の液状多価アルコール;アセトン等のケトン類;エチルエーテル等のエーテル類;酢酸エチル等のエステル類;等の一種又は二種以上を用いることができる。水と低級一価アルコールとの混合液を用いるのが好ましい。抽出は、前記ヒヒラギギクを室温又は加温下で溶媒中に所定の時間浸漬することによって実施できる。また、抽出前に、乾燥、細切、圧搾又は醗酵等の前処理を行うこともできる。 The daisies extract used in the present invention can be prepared by a general method. For example, it may be an extract of any part of the roots, stems, stems, leaves, flowers, etc. of daisies, and an extract obtained from two or more parts may be mixed or used. Two or more kinds of extracts extracted with different solvents from more than one part may be used. Although it does not specifically limit as an extraction solvent, For example, Water; Lower monohydric alcohols, such as methyl alcohol and ethyl alcohol; Liquid polyhydric alcohols, such as glycerol, propylene glycol, and 1, 3- butylene glycol; Ketones, such as acetone; Ethyl One or more of ethers such as ether; esters such as ethyl acetate; and the like can be used. It is preferable to use a mixed solution of water and a lower monohydric alcohol. The extraction can be performed by immersing the daisies in a solvent at room temperature or under heating for a predetermined time. Moreover, pre-processing, such as drying, shredding, pressing or fermentation, can also be performed before extraction.
前記ヒヒラギギク抽出物は、調製後、そのままコラーゲン産生促進剤として用いることができる。また、所望により、適宜の期間そのまま放置し熟成させた後に、コラーゲン産生促進剤として用いることもできる。必要ならば、本発明の効果に影響のない範囲で、更に、濾過又はイオン交換樹脂等により、脱臭、脱色等の精製処理を施して用いることもできる。又、液体クロマトグラフィー等の分離手段を用い、活性の高い画分を取り出して用いることもできる。 The said daisies extract can be used as a collagen production promoter as it is after preparation. Further, if desired, it can be used as a collagen production promoter after being left to mature for an appropriate period. If necessary, it can be used after being subjected to a purification treatment such as deodorization and decolorization by filtration or ion exchange resin within a range that does not affect the effect of the present invention. Further, a fraction having high activity can be taken out and used by using a separation means such as liquid chromatography.
前記ヒヒラギギク抽出物の好ましい調製方法の例としては、ヒヒラギギクの根、茎、葉、花等をそのまま、或いは乾燥させたもの、又は細切・粉砕したもの等を、水;メタノール、エタノール等の低級一価アルコール;グリセリン、プロピレングリコール、1,3−ブチレングリコール等の多価アルコール;等の親水性極性溶媒又はこれらの2種以上の混合溶媒に加温し又は室温にて浸漬させた後、抽出して得ることができる。但し、抽出法はこれに限定されるものではない。 Examples of preferred methods for preparing the daisies extract include daisies roots, stems, leaves, flowers, etc. as they are or dried, or chopped and crushed, etc. Monohydric alcohol; polyhydric alcohol such as glycerin, propylene glycol, 1,3-butylene glycol; etc .; heated in a hydrophilic polar solvent or a mixed solvent of two or more of these or soaked at room temperature, and then extracted Can be obtained. However, the extraction method is not limited to this.
前記ヒヒラギギク抽出物は、液状、ペースト状、ゲル状等いずれの形態であってもよい。抽出溶媒を含む液状の抽出物を、減圧乾燥、又は凍結乾燥などにより乾固させて固体状とした後に用いることもできる。また、スプレードライ等により乾燥させて粉末として用いることもできる。 The daisies extract may be in any form such as liquid, paste or gel. The liquid extract containing the extraction solvent can also be used after it is solidified by drying under reduced pressure or freeze drying. It can also be dried by spray drying or the like and used as a powder.
本発明は、本発明のコラーゲン産生促進剤であるヒヒラギギク抽出物を有効成分として含有する老化防止用皮膚外用剤にも関する。本発明の皮膚外用剤は、ヒヒラギギク抽出物のコラーゲン産生促進作用によって、優れた老化防止効果を奏する。ヒヒラギギク抽出物のコラーゲン産生促進作用は、主には線維芽細胞に対する賦活作用に起因するものと考えられるが、ヒヒラギギク抽出物は、従来の線維芽細胞賦活剤(例えばVC−PMg)と比較して、コラーゲン産生促進作用が特に高いという特徴がある。従って、本発明の皮膚外用剤は、真皮内のコラーゲン量が低下すること、及び真皮内のコラーゲンが老化することに起因する皮膚老化に対して、特に優れた防止効果を奏する。本発明の皮膚外用剤中の前記ヒヒラギギク抽出物の含有量は、固形分として、好ましくは0.00001〜2質量%(以下単に「%」で示す)であり、より好ましくは0.0001〜1%である。この範囲内であれば、前記抽出物を安定に配合することができ、かつ高い老化防止効果を発揮することができる。 The present invention also relates to an anti-aging skin external preparation containing, as an active ingredient, a daisy extract that is a collagen production promoter of the present invention. The external preparation for skin of the present invention exhibits an excellent anti-aging effect due to the collagen production-promoting action of the daisies extract. Collagen production promoting action of the daisies extract is considered to be mainly due to the activation action on fibroblasts, but the daisies extract is compared with conventional fibroblast activators (for example, VC-PMg). The collagen production promoting action is particularly high. Therefore, the external preparation for skin of the present invention has a particularly excellent preventive effect against skin aging caused by a decrease in the amount of collagen in the dermis and aging of the collagen in the dermis. The content of the leeky extract in the external preparation for skin of the present invention is preferably 0.00001 to 2% by mass (hereinafter simply referred to as “%”), more preferably 0.0001 to 1 as a solid content. %. If it exists in this range, the said extract can be mix | blended stably and the high anti-aging effect can be exhibited.
本発明の皮膚外用剤は、前記コラーゲン産生促進剤を常法に従い、種々の形態の基剤に配合して製剤化することにより調製できる。更に、前記コラーゲン産生促進剤を他の薬効剤の一種又は二種以上と組み合わせて配合することによって、コラーゲン産生促進効果をより高めた、もしくはコラーゲン産生促進効果とともに他の薬効も奏する皮膚外用剤を調製することができる。他の薬効剤の例には、美白剤、紫外線防御剤、抗菌剤、抗炎症剤、細胞賦活剤、活性酸素除去剤、及び保湿剤などが含まれるが、これらに限定されることはない。 The external preparation for skin of the present invention can be prepared by blending the collagen production promoter with various forms of bases according to a conventional method. Further, by adding the collagen production promoter in combination with one or more of other medicinal agents, a skin external preparation that further enhances the collagen production promoting effect or exhibits other medicinal effects together with the collagen production promoting effect. Can be prepared. Examples of other medicinal agents include, but are not limited to, whitening agents, UV protection agents, antibacterial agents, anti-inflammatory agents, cell activators, active oxygen scavengers, and humectants.
美白剤の例には、アスコルビン酸又はその誘導体、アルブチン、エラグ酸、リノール酸、ビタミンE及びその誘導体、グリチルリチン酸及びその誘導体、トラネキサム酸、胎盤抽出物、カミツレ抽出物、カンゾウ抽出物、エイジツ抽出物、オウゴン抽出物、海藻抽出物、クジン抽出物、ケイケットウ抽出物、ゴカヒ抽出物、コメヌカ抽出物、小麦胚芽抽出物、サイシン抽出物、サンザシ抽出物、サンペンズ抽出物、シラユリ抽出物、シャクヤク抽出物、センプクカ抽出物、大豆抽出物、茶抽出物、糖蜜抽出物、ビャクレン抽出物、ブドウ抽出物、ホップ抽出物、マイカイカ抽出物、モッカ抽出物、ユキノシタ抽出物等が含まれる。 Examples of whitening agents include ascorbic acid or derivatives thereof, arbutin, ellagic acid, linoleic acid, vitamin E and derivatives thereof, glycyrrhizic acid and derivatives thereof, tranexamic acid, placenta extract, chamomile extract, licorice extract, age extract , Ogon extract, seaweed extract, cucumber extract, caquette extract, gokahi extract, rice bran extract, wheat germ extract, saicin extract, hawthorn extract, sun penz extract, shirayuri extract, peony extract Sempukuka extract, soybean extract, tea extract, molasses extract, sandalwood extract, grape extract, hop extract, micaika extract, mokka extract, yukinoshita extract and the like.
紫外線防御剤としては、例えば、パラメトキシケイ皮酸−2−エチルヘキシル、2−ヒドロキシ−4−メトキシベンゾフェノン、2−ヒドロキシ−4−メトキシベンゾフェノン−5−硫酸ナトリウム、4−t−ブチル−4’−メトキシジベンゾイルメタン、2−フェニル−ベンズイミダゾール−5−硫酸、酸化チタン、酸化亜鉛等が挙げられる。 Examples of the UV protection agent include paramethoxycinnamate-2-ethylhexyl, 2-hydroxy-4-methoxybenzophenone, 2-hydroxy-4-methoxybenzophenone-5 sodium sulfate, 4-t-butyl-4′- Examples thereof include methoxydibenzoylmethane, 2-phenyl-benzimidazole-5-sulfuric acid, titanium oxide, and zinc oxide.
抗菌剤としては、例えば、安息香酸、安息香酸ナトリウム、パラオキシ安息香酸エステル、塩化ベンザルコニウム、フェノキシエタノール、イソプロピルメチルフェノール等が挙げられる。 Examples of the antibacterial agent include benzoic acid, sodium benzoate, p-hydroxybenzoate ester, benzalkonium chloride, phenoxyethanol, isopropylmethylphenol, and the like.
抗炎症剤としては、例えば、イオウ及びその誘導体、グリチルリチン酸及びその誘導体、グリチルレチン酸及びその誘導体、アルテア抽出物、アシタバ抽出物、アルニカ抽出物、インチンコウ抽出物、イラクサ抽出物、オウバク抽出物、オトギリソウ抽出物、カミツレ抽出物、キンギンカ抽出物、クレソン抽出物、コンフリー抽出物、サルビア抽出物、シコン抽出物、シソ抽出物、シラカバ抽出物、ゲンチアナ抽出物等が挙げられる。 Anti-inflammatory agents include, for example, sulfur and its derivatives, glycyrrhizic acid and its derivatives, glycyrrhetinic acid and its derivatives, artea extract, ashitaba extract, arnica extract, ginseng extract, nettle extract, buckwheat extract, hypericum Examples include extracts, chamomile extracts, goldfish extract, watercress extract, comfrey extract, salvia extract, sicon extract, perilla extract, birch extract, gentian extract and the like.
細胞賦活剤の例には、カフェイン、鶏冠抽出物、貝殻抽出物、貝肉抽出物、ローヤルゼリー、シルクプロテイン及びその分解物又はそれらの誘導体、ラクトフェリン又はその分解物、コンドロイチン硫酸、ヒアルロン酸等のムコ多糖類またはそれらの塩、コラーゲン、酵母抽出物、乳酸菌抽出物、ビフィズス菌抽出物、醗酵代謝抽出物、イチョウ抽出物、オオムギ抽出物、センブリ抽出物、タイソウ抽出物、ニンジン抽出物、ローズマリー抽出物、グリコール酸、クエン酸、乳酸、リンゴ酸、酒石酸、コハク酸等が含まれる。 Examples of cell activators include caffeine, chicken crown extract, shell extract, shell extract, royal jelly, silk protein and its degradation products or derivatives thereof, lactoferrin or degradation products thereof, chondroitin sulfate, hyaluronic acid, etc. Mucopolysaccharides or their salts, collagen, yeast extract, lactic acid bacteria extract, bifidobacteria extract, fermentation metabolic extract, ginkgo biloba extract, barley extract, assembly extract, peanut extract, carrot extract, rosemary Extracts, glycolic acid, citric acid, lactic acid, malic acid, tartaric acid, succinic acid and the like are included.
活性酸素除去剤は、過酸化脂質生成抑制等の作用を有しており、例えば、スーパーオキサイドディスムターゼ、マンニトール、クエルセチン、カテキン及びその誘導体、ルチン及びその誘導体、ボタンピ抽出物、ヤシャジツ抽出物、メリッサ抽出物、羅漢果抽出物、レチノール及びその誘導体、カロチノイド等のビタミンA類、チアミンおよびその誘導体、リボフラビンおよびその誘導体、ピリドキシンおよびその誘導体、ニコチン酸およびその誘導体等のビタミンB類、トコフェロール及びその誘導体等のビタミンE類、ジブチルヒドロキシトルエン及びブチルヒドロキシアニソール等が挙げられる。 The active oxygen scavenger has an action such as suppression of lipid peroxide production. For example, superoxide dismutase, mannitol, quercetin, catechin and derivatives thereof, rutin and derivatives thereof, button pi extract, yashajitsu extract, melissa extract , Lanahan fruit extract, retinol and its derivatives, vitamin A such as carotenoid, thiamine and its derivative, riboflavin and its derivative, pyridoxine and its derivative, vitamin B such as nicotinic acid and its derivative, tocopherol and its derivative, etc. Vitamin E, dibutylhydroxytoluene, butylhydroxyanisole, etc. are mentioned.
保湿剤としては、例えば、エラスチン、ケラチン等のタンパク質またはそれらの誘導体、加水分解物並びにそれらの塩、グリシン、セリン、アスパラギン酸、グルタミン酸、アルギニン、テアニン等のアミノ酸及びそれらの誘導体、ソルビトール、エリスリトール、トレハロース、イノシトール、グルコース、蔗糖およびその誘導体、デキストリン及びその誘導体、ハチミツ等の糖類、D−パンテノール及びその誘導体、尿素、リン脂質、セラミド、オウレン抽出物、ショウブ抽出物、ジオウ抽出物、センキュウ抽出物、ゼニアオイ抽出物、タチジャコウソウ抽出物、ドクダミ抽出物、ハマメリス抽出物、ボダイジュ抽出物、マロニエ抽出物、マルメロ抽出物等が挙げられる。 Examples of the humectant include proteins such as elastin and keratin or derivatives thereof, hydrolysates and salts thereof, amino acids such as glycine, serine, aspartic acid, glutamic acid, arginine and theanine and derivatives thereof, sorbitol, erythritol, Trehalose, inositol, glucose, sucrose and derivatives thereof, dextrin and derivatives thereof, saccharides such as honey, D-panthenol and derivatives thereof, urea, phospholipid, ceramide, auren extract, ginger extract, diautum extract, sensyu extract Product, mallow extract, gypsophila extract, dokudami extract, hamamelis extract, bodaige extract, maronier extract, quince extract and the like.
また、本発明の皮膚外用剤には、本発明のコラーゲン産生促進剤以外の任意の成分を配合することができる。そのような成分としては、例えば、アミノ酸、脂質、糖、ホルモン、酵素、核酸などの生理活性物質等を挙げることができるが、これらに限定されることはない。また、本発明の効果を損なわない範囲で、化粧料や医薬部外品、皮膚外用剤等の製造に通常使用される成分、例えば、水(精製水、温泉水、深層水等)、油剤、界面活性剤、金属セッケン、ゲル化剤、粉体、アルコール類、水溶性高分子、皮膜形成剤、樹脂、包接化合物、香料、消臭剤、塩類、pH調整剤、清涼剤、植物・動物・微生物由来の抽出物、血行促進剤、収斂剤、抗脂漏剤、キレート剤、角質溶解剤、酵素、ホルモン類、他のビタミン類等を必要に応じて用いることができる。 Moreover, arbitrary components other than the collagen production promoter of this invention can be mix | blended with the skin external preparation of this invention. Examples of such components include, but are not limited to, physiologically active substances such as amino acids, lipids, sugars, hormones, enzymes, and nucleic acids. In addition, components that are usually used in the production of cosmetics, quasi-drugs, skin external preparations and the like, for example, water (purified water, hot spring water, deep water, etc.), oil agents, Surfactant, metal soap, gelling agent, powder, alcohol, water-soluble polymer, film-forming agent, resin, inclusion compound, fragrance, deodorant, salt, pH adjuster, refreshing agent, plant / animal -Extracts derived from microorganisms, blood circulation promoters, astringents, antiseborrheic agents, chelating agents, keratolytic agents, enzymes, hormones, other vitamins and the like can be used as necessary.
本発明の皮膚外用剤は、パウダー、パウダーファンデーション等の粉体;石けん、リップスティック等の固体;クリーム、乳液、クリームファンデーション等の乳化物;化粧水、美容液等の液体;など、種々の形態の化粧料組成物であるのが好ましい。但し、これらに限定されるものではない。 The external preparation for skin of the present invention has various forms such as powders such as powder and powder foundation; solids such as soap and lipstick; emulsions such as cream, emulsion and cream foundation; It is preferable that it is a cosmetic composition. However, it is not limited to these.
以下に実施例を挙げて本発明を更に具体的に説明するが、本発明の範囲は下記の実施例に限定されることはない。
[例1:ヒヒラギギク抽出液の調製]
ヒヒラギギクの茎・葉部位の乾燥物を粉砕し、当該粉砕物100gに対して、50体積%エタノール水溶液1,000mLを加え、室温にて7日間攪拌抽出を行った。これを遠心分離・加圧ろ過し、抽出液900gを得た(このときの乾燥固形分量は0.8gであった)。
EXAMPLES Hereinafter, the present invention will be described more specifically with reference to examples. However, the scope of the present invention is not limited to the following examples.
[Example 1: Preparation of leeks extract]
The dried product of the stems and leaves of daisies was pulverized, and 1,000 mL of a 50% by volume aqueous ethanol solution was added to 100 g of the pulverized product, followed by stirring and extraction at room temperature for 7 days. This was centrifuged and filtered under pressure to obtain 900 g of an extract (the amount of dry solid at this time was 0.8 g).
[例2:ヒヒラギギク抽出液のコラーゲン産生試験]
培地として、10%ウシ子牛血清(FBS)含有ダルベッコ変法イーグルMEM培地(DMEM、ニッスイ)を使用し、ヒト新生児由来の線維芽細胞NB1RGBを、12穴プレートに3×105細胞/ウェル(穴)で播種した。1ウェル中の培地量は400μLとした。細胞定着後、例1で調製したヒヒラギギク抽出液を、培地に対して0、0.1、及び1体積%になる濃度で添加した、5%ウシ子牛血清(FBS)含有ダルベッコ変法イーグルMEM培地を加え、4日間培養した。4日後に、細胞培地を回収し、以下の方法で、培地中に産生されたコラーゲン量、及び細胞数比を測定及び算出した。
なお、陽性対照として、線維芽細胞に対する賦活作用があることが知られているVC−PMgを、ヒヒラギギク抽出液の代わりに0.01体積%添加した培地試料についても同様に培養した。その後、同様にコラーゲン量及び細胞数比を求めた。
[Example 2: Collagen production test of leeks extract]
As a medium, Dulbecco's modified Eagle's MEM medium (DMEM, Nissui) containing 10% calf serum (FBS) was used, and human neonatal fibroblasts NB1RGB were added to 3 × 10 5 cells / well (12-well plate). Sowing). The amount of medium in one well was 400 μL. After cell fixation, Dulbecco's modified Eagle MEM containing 5% calf serum (FBS) added with daisies extract prepared in Example 1 at concentrations of 0, 0.1 and 1% by volume with respect to the medium. Medium was added and cultured for 4 days. Four days later, the cell culture medium was collected, and the amount of collagen produced in the culture medium and the cell number ratio were measured and calculated by the following method.
In addition, as a positive control, a medium sample containing 0.01% by volume of VC-PMg, which is known to have an activating effect on fibroblasts, instead of the dairy extract was also cultured in the same manner. Thereafter, the amount of collagen and the cell number ratio were similarly determined.
(コラーゲン量の測定及び算出)
各試料培地中のコラーゲン量は、可溶性コラーゲンに特異的に結合する染料を利用したコラーゲン分析キット(SicrolCollagenassaykit;Sircol社製)を用いて定量した。具体的には、各試料培地から、培地150μLをチューブに移し、1.0mLの上記コラーゲン分析キットの検液(SircolDyeReagent)を添加し、温度37℃で30分間混合した。混合物を回転数1500rpmで10分間遠心分離して、上澄み液を除去した。再び、上記コラーゲン分析キットの検液を1.0mL添加し、ゆっくり混合した後、波長540nmの吸光度を測定した。
下記表にその測定値から、算出されたコラーゲン産生量Cを示す。
(Measurement and calculation of collagen content)
The amount of collagen in each sample medium was quantified using a collagen analysis kit (SicrolCollagenassaykit; manufactured by Sircol) using a dye that specifically binds to soluble collagen. Specifically, 150 μL of the medium from each sample medium was transferred to a tube, 1.0 mL of the collagen analysis kit test solution (SircolDyeReagent) was added, and the mixture was mixed at a temperature of 37 ° C. for 30 minutes. The mixture was centrifuged at 1500 rpm for 10 minutes, and the supernatant was removed. Again, 1.0 mL of the collagen analysis kit test solution was added and mixed slowly, and then the absorbance at a wavelength of 540 nm was measured.
The following table shows the amount of collagen production C calculated from the measured values.
(細胞数比の測定及び算出)
各試料培地中の細胞数は、新鮮な培地に交換した後、MTTアッセイ試薬を加えて培養し、その培養液の波長490nmの吸光度を測定し、測定値から算出されるホルマザン量に基づいて算出した。下記表にその結果を示す。表中の値は、試料液を添加していない試料培地中の細胞数を100として、それに対する細胞数比Mとして算出した値である。
(Measurement and calculation of cell number ratio)
The number of cells in each sample medium is replaced with a fresh medium, cultured with MTT assay reagent added, the absorbance of the culture solution measured at a wavelength of 490 nm, and calculated based on the amount of formazan calculated from the measured value. did. The results are shown in the following table. The values in the table are values calculated as a cell number ratio M with respect to 100 as the number of cells in the sample medium to which no sample solution is added.
(コラーゲン産生量の補正値)
さらに、下記表中に、各試料培地中に産生したコラーゲン量Cを、上記方法によって算出された細胞数比Mで割った値も併せて示す。この補正値C/Mは、同数の線維芽細胞当たりのコラーゲン産生量の指標となり、試料液の線維芽細胞に対するコラーゲン産生促進作用を直接的に示す値である。
(Correction value for collagen production)
Further, the following table also shows the value obtained by dividing the amount of collagen C produced in each sample medium by the cell number ratio M calculated by the above method. This correction value C / M serves as an index of the amount of collagen production per fibroblast of the same number, and is a value that directly indicates the collagen production promoting action on the fibroblasts of the sample solution.
上記表に示す結果から、ヒヒラギギク抽出液は、細胞賦活剤として公知のVC−PMgと比較して、高いコラーゲン産生促進作用を示すことが理解できる。特に、コラーゲン産生量Cを細胞数比Mで割った補正値C/Mを比較すると、ヒヒラギギク抽出液のコラーゲン産生促進作用が格段に高いことが理解できる。 From the results shown in the above table, it can be understood that the daisies extract shows a higher collagen production promoting effect than VC-PMg known as a cell activator. In particular, when the correction value C / M obtained by dividing the collagen production amount C by the cell number ratio M is compared, it can be understood that the action of accelerating the collagen production by the hilaragi extract is remarkably high.
[例3:クレンジングクリームの調製例]
以下の組成のクレンジングクリームを、以下の方法で調製した。
(製法)
A.下記成分(1)〜(9)を加熱溶解し、70℃に保つ。
B.下記成分(10)〜(14)を加熱溶解し、70℃に保つ。
C.BにAを加え乳化する。
D.Cを冷却後、下記成分(15)及び(16)を加え混合し、クレンジングクリームを得た。
(成分) (%)
(1)ステアリン酸 2.0
(2)ステアリルアルコール 3.0
(3)親油型モノステアリン酸グリセリル 2.0
(4)ミツロウ 1.5
(5)ワセリン 6.0
(6)流動パラフィン 40.0
(7)ジメチルポリシロキサン(100CS) 0.5
(8)セスキオレイン酸ソルビタン 1.0
(9)防腐剤 適量
(10)トリエタノールアミン 1.0
(11)プロピレングリコール 10.0
(12)ポリエチレングリコール20000 0.5
(13)カルボキシビニルポリマー1%溶液 5.0
(14)精製水 残量
(15)ヒヒラギギク抽出液*1 0.1
(16)香料 適量
*1 例1で調製した抽出液
[Example 3: Preparation of cleansing cream]
A cleansing cream having the following composition was prepared by the following method.
(Manufacturing method)
A. The following components (1) to (9) are dissolved by heating and maintained at 70 ° C.
B. The following components (10) to (14) are dissolved by heating and maintained at 70 ° C.
C. A is added to B and emulsified.
D. After cooling C, the following components (15) and (16) were added and mixed to obtain a cleansing cream.
(Ingredient) (%)
(1) Stearic acid 2.0
(2) Stearyl alcohol 3.0
(3) Lipophilic glyceryl monostearate 2.0
(4) Beeswax 1.5
(5) Vaseline 6.0
(6) Liquid paraffin 40.0
(7) Dimethylpolysiloxane (100CS) 0.5
(8) Sorbitan sesquioleate 1.0
(9) Preservative appropriate amount (10) Triethanolamine 1.0
(11) Propylene glycol 10.0
(12) Polyethylene glycol 20000 0.5
(13) Carboxyvinyl polymer 1% solution 5.0
(14) Purified water Remaining amount (15) Hilaragiku extract * 1 0.1
(16) Perfume appropriate amount * 1 Extract prepared in Example 1
調製したクレンジングクリームは、メイク汚れとのなじみがよく、すっきりとメイク汚れが落ち、肌には適度なうるおいとエモリエント感があり、べたつきのないクレンジングクリームであった。 The prepared cleansing cream had a good fit with makeup stains, clean makeup stains removed, moderate moisture and emollient on the skin, and was a non-sticky cleansing cream.
[例4:洗顔料の調製例]
以下の組成の洗顔料を以下の方法で製造した。
(製法)
A.下記成分(1)〜(5)を加熱溶解する。
B.下記成分(6)及び(7)を加熱溶解する。
C.下記成分(8)〜(11)を加熱溶解する。
D.AにBを加え混合後、更にCを加え混合する。
E.Dを冷却後、下記成分(12)、(13)及び(14)を加え混合し、洗顔料を得た。
(成分) %
(1)ラウリン酸 5.0
(2)ミリスチン酸 18.5
(3)ステアリン酸 6.0
(4)グリセリン 12.0
(5)ポリエチレングリコール1500 5.0
(6)水酸化カリウム 6.5
(7)精製水 残量
(8)ヤシ油脂肪酸ジエタノールアミド 5.0
(9)ヤシ油脂肪酸メチルタウリンナトリウム 1.8
(10)ポリオキシエチレン(7.5E.O.)ラウリル
エーテル 2.0
(11)ジステアリン酸エチレングリコール 1.0
(12)ヒドロキシプロピルメチルセルロース1%水溶液 5.0
(13)ヒヒラギギク抽出液*1 0.1
(14)香料 適量
*1 例1で調製した抽出液
[Example 4: Preparation of face wash]
A face wash having the following composition was produced by the following method.
(Manufacturing method)
A. The following components (1) to (5) are dissolved by heating.
B. The following components (6) and (7) are dissolved by heating.
C. The following components (8) to (11) are dissolved by heating.
D. Add B to A and mix, then add C and mix.
E. After cooling D, the following components (12), (13) and (14) were added and mixed to obtain a face wash.
(Ingredient)%
(1) Lauric acid 5.0
(2) Myristic acid 18.5
(3) Stearic acid 6.0
(4) Glycerin 12.0
(5) Polyethylene glycol 1500 5.0
(6) Potassium hydroxide 6.5
(7) Purified water remaining amount (8) Palm oil fatty acid diethanolamide 5.0
(9) Palm oil fatty acid methyl taurine sodium 1.8
(10) Polyoxyethylene (7.5E.O.) lauryl ether 2.0
(11) Ethylene glycol distearate 1.0
(12) Hydroxypropyl methylcellulose 1% aqueous solution 5.0
(13) Hilaragiku extract * 1 0.1
(14) Perfume appropriate amount * 1 Extract prepared in Example 1
調製した洗顔料は、豊かでコクのある泡立ちで、汚れ落ちもよく、すっきりと洗いあがり、肌にうるおいが残る洗顔料であった。 The prepared face wash was rich and rich in foaming, had good stain removal, washes cleanly, and remained moist on the skin.
[例5:化粧水1の調製例]
以下の組成の化粧水1を以下の方法で調製した。
(製法)
A.下記成分(1)〜(7)を混合溶解する。
B.下記成分(8)〜(11)を混合溶解する。
C.AにBを加え混合し、化粧水を得た。
(成分) %
(1)クエン酸 0.05
(2)クエン酸ナトリウム 0.2
(3)ピロリドンカルボン酸ナトリウム(50%)液 0.5
(4)ヒヒラギギク抽出液*1 0.05
(5)グリセリン 3.0
(6)1,3−ブチレングリコール 8.0
(7)精製水 残量
(8)エチルアルコール 10.0
(9)香料 適量
(10)防腐剤 適量
(11)モノオレイン酸ポリオキシエチレン(20E.O.)
ソルビタン 0.5
*1 例1で調製した抽出液
[Example 5: Preparation example of lotion 1]
A lotion 1 having the following composition was prepared by the following method.
(Manufacturing method)
A. The following components (1) to (7) are mixed and dissolved.
B. The following components (8) to (11) are mixed and dissolved.
C. B was added to A and mixed to obtain a skin lotion.
(Ingredient)%
(1) Citric acid 0.05
(2) Sodium citrate 0.2
(3) Sodium pyrrolidonecarboxylate (50%) solution 0.5
(4) Hilaragiku extract * 1 0.05
(5) Glycerin 3.0
(6) 1,3-butylene glycol 8.0
(7) Purified water remaining amount (8) Ethyl alcohol 10.0
(9) Perfume Appropriate amount (10) Preservative Appropriate amount (11) Polyoxyethylene monooleate (20E.O.)
Sorbitan 0.5
* 1 Extract prepared in Example 1
調製した化粧水1は、みずみずしい使用感があり、肌のうるおいに優れ、キメを整え、つややはり、弾力のある美しい肌とすることができる化粧水であった。 The prepared lotion 1 was a lotion that had a fresh feeling of use, was excellent in moisture of the skin, adjusted the texture, and was able to make the skin beautiful and elastic.
[例6:化粧水2の調製例]
以下の組成物の化粧水2を以下の方法で調製した。
(製法)
A.下記成分(1)〜(7)を混合溶解する。
B.下記成分(8)〜(12)を混合溶解する。
C.BにAを加え混合し、化粧水を得る。
(成分) %
(1)メドウホーム油 0.05
(2)ホホバ油 0.05
(3)香料 適量
(4)防腐剤 適量
(5)モノオレイン酸ポリオキシエチレン(20E.O.)
ソルビタン 0.5
(6)イソステアリン酸ポリオキシエチレン硬化
ヒマシ油(50E.O.) 1.0
(7)エチルアルコール 8.0
(8)グリセリン 5.0
(9)1,3−ブチレングリコール 5.0
(10)ポリエチレングリコール1500 0.1
(11)ヒヒラギギク抽出液*1 0.2
(12)精製水 残量
*1 例1で調製した抽出液
[Example 6: Preparation example of lotion 2]
A lotion 2 having the following composition was prepared by the following method.
(Manufacturing method)
A. The following components (1) to (7) are mixed and dissolved.
B. The following components (8) to (12) are mixed and dissolved.
C. A is added to B and mixed to obtain a skin lotion.
(Ingredient)%
(1) Meadow Home Oil 0.05
(2) Jojoba oil 0.05
(3) Perfume appropriate amount (4) preservative appropriate amount (5) polyoxyethylene monooleate (20E.O.)
Sorbitan 0.5
(6) Isostearic acid polyoxyethylene hydrogenated castor oil (50 EO) 1.0
(7) Ethyl alcohol 8.0
(8) Glycerin 5.0
(9) 1,3-butylene glycol 5.0
(10) Polyethylene glycol 1500 0.1
(11) Hilaragiku extract * 1 0.2
(12) Purified water remaining * 1 Extract prepared in Example 1
調製した化粧水2は、なめらかな使用感があり、肌のうるおいに優れ、キメを整え、つややはり、弾力のある美しい肌とすることができる化粧水であった。 The prepared lotion 2 was a lotion that had a smooth feeling of use, was excellent in moisture of the skin, adjusted the texture, and was able to give a beautiful skin with elasticity.
[例7:化粧水3の調製例]
以下の組成の化粧水3を以下の方法で調製した。
(製法)
A.下記成分(1)〜(8)を混合溶解する。
B.下記成分(9)〜(12)を混合溶解する。
C.BにAを加え乳化し、化粧水を得る。
(成分) %
(1)トリ2−エチルヘキサン酸グリセリル 0.08
(2)スクワラン 0.02
(3)セスキオレイン酸ソルビタン 0.05
(4)モノオレイン酸ポリオキシエチレン(20E.O.)
ソルビタン 0.05
(5)ポリオキシエチレン(8E.O.)アルキル(12〜15)
エーテルリン酸 0.1
(6)防腐剤 適量
(7)香料 適量
(8)エチルアルコール 8.0
(9)ジプロプレングリコール 8.0
(10)グリセリン 4.0
(11)ヒヒラギギク抽出液*1 0.1
(12)精製水 残量
*1 例1で調製した抽出液
[Example 7: Preparation example of lotion 3]
A lotion 3 having the following composition was prepared by the following method.
(Manufacturing method)
A. The following components (1) to (8) are mixed and dissolved.
B. The following components (9) to (12) are mixed and dissolved.
C. A is added to B and emulsified to obtain a skin lotion.
(Ingredient)%
(1) Glyceryl tri-2-ethylhexanoate 0.08
(2) Squalane 0.02
(3) Sorbitan sesquioleate 0.05
(4) Polyoxyethylene monooleate (20E.O.)
Sorbitan 0.05
(5) Polyoxyethylene (8E.O.) alkyl (12-15)
Ether phosphoric acid 0.1
(6) Preservative appropriate amount (7) perfume appropriate amount (8) ethyl alcohol 8.0
(9) Dipropylene glycol 8.0
(10) Glycerin 4.0
(11) Hilaragiku extract * 1 0.1
(12) Purified water remaining * 1 Extract prepared in Example 1
調製した化粧水3は、みずみずしくすっきりとした使用感があり、肌のうるおいに優れ、キメを整え、つややはり、弾力のある美しい肌にすることができる化粧水であった。 The prepared lotion 3 was a lotion that had a fresh and refreshing feeling of use, was excellent in moisture of the skin, adjusted the texture, and was able to make the skin beautiful and elastic.
[例8:乳液の調製例]
以下の組成の乳液を以下の方法により調製した。
(製法)
A.下記成分(1)〜(10)を加熱溶解し、70℃に保つ。
B.下記成分(11)〜(15)を加熱溶解し、70℃に保つ。
C.AにBを加え乳化し、更に下記成分(16)を加え混合する。
D.Cを冷却し、下記成分(17)及び(18)を加え混合し、乳液を得る。
(成分) %
(1)ステアリン酸 1.0
(2)セタノール 0.5
(3)親油型モノステアリン酸グリセリン 0.5
(4)流動パラフィン 2.0
(5)スクワラン 3.0
(6)ホホバ油 3.0
(7)パルミチン酸セチル 0.2
(8)防腐剤 適量
(9)モノステアリン酸ソルビタン 0.3
(10)モノオレイン酸ポリオキシエチレン(20E.O.)
ソルビタン 0.5
(11)トリエタノールアミン 0.5
(12)1,3−ブチレングリコール 15.0
(13)グリセリン 3.0
(14)ポリエチレングリコール6000 0.5
(15)精製水 残量
(16)カルボキシビニルポリマー1%溶液 8.0
(17)ヒヒラギギク抽出液*1 0.2
(18)香料 適量
*1 例1で調製した抽出液
[Example 8: Preparation of emulsion]
An emulsion having the following composition was prepared by the following method.
(Manufacturing method)
A. The following components (1) to (10) are dissolved by heating and maintained at 70 ° C.
B. The following components (11) to (15) are dissolved by heating and maintained at 70 ° C.
C. B is added to A to emulsify, and the following component (16) is further added and mixed.
D. C is cooled, the following components (17) and (18) are added and mixed to obtain an emulsion.
(Ingredient)%
(1) Stearic acid 1.0
(2) Cetanol 0.5
(3) Lipophilic glyceryl monostearate 0.5
(4) Liquid paraffin 2.0
(5) Squalane 3.0
(6) Jojoba oil 3.0
(7) Cetyl palmitate 0.2
(8) Preservative appropriate amount (9) Sorbitan monostearate 0.3
(10) Polyoxyethylene monooleate (20E.O.)
Sorbitan 0.5
(11) Triethanolamine 0.5
(12) 1,3-butylene glycol 15.0
(13) Glycerin 3.0
(14) Polyethylene glycol 6000 0.5
(15) Purified water Remaining amount (16) Carboxyvinyl polymer 1% solution 8.0
(17) Hilaragiku extract * 1 0.2
(18) Perfume appropriate amount * 1 Extract prepared in Example 1
調製した乳液は、みずみずしくなめらかな使用感があり、肌のうるおいとエモリエンと感に優れ、キメを整え、つややはり、弾力のある美しい肌にすることができる乳液であった。 The prepared emulsion had a fresh and smooth feeling of use, was excellent in moisture and emollient, had a smooth texture, and was able to give beautiful skin with elasticity.
[例9:クリームの調製例]
以下の組成のクレームを以下の方法で調製した。
(製法)
A.下記成分(1)〜(13)を加熱溶解し、70℃に保つ。
B.下記成分(14)〜(18)を加熱溶解し、70℃に保つ。
C.AにBを加え乳化し、更に下記成分(19)を加え混合する。
D.Cを冷却し、下記成分(20)及び(21)を加え混合し、乳液を得る。
(成分) %
(1)ステアリン酸 2.5
(2)セタノール 2.5
(3)親油型モノステアリン酸グリセリン 2.0
(4)ワセリン 2.0
(5)ジペンタエリトリット脂肪酸エステル*1 2.0
(6)ミリスチン酸イソトリデシル 5.0
(7)流動パラフィン 8.0
(8)スクワラン 5.0
(9)ミツロウ 1.0
(10)パルミチン酸セチル 2.0
(11)セスキオレイン酸ソルビタン 0.5
(12)モノオレイン酸ポリオキシエチレン(20E.O.)
ソルビタン 1.5
(13)防腐剤 適量
(14)トリエタノールアミン 1.2
(15)1,3−ブチレングリコール 8.0
(16)グリセリン 2.0
(17)ポリエチレングリコール20000 0.5
(18)精製水 残量
(19)カルボキシビニルポリマー1%水溶液 5.0
(20)ヒヒラギギク抽出液*2 1.0
(21)香料 適量
*1:コスモール168AR(日清オイリオグループ社製)
*2 例1で調製した抽出液
[Example 9: Preparation example of cream]
The following compositional claims were prepared in the following manner.
(Manufacturing method)
A. The following components (1) to (13) are dissolved by heating and maintained at 70 ° C.
B. The following components (14) to (18) are dissolved by heating and maintained at 70 ° C.
C. B is added to A to emulsify, and the following component (19) is further added and mixed.
D. C is cooled, and the following components (20) and (21) are added and mixed to obtain an emulsion.
(Ingredient)%
(1) Stearic acid 2.5
(2) Cetanol 2.5
(3) Lipophilic glyceryl monostearate 2.0
(4) Vaseline 2.0
(5) Dipentaerythritol fatty acid ester * 1 2.0
(6) Isotridecyl myristate 5.0
(7) Liquid paraffin 8.0
(8) Squalane 5.0
(9) Beeswax 1.0
(10) Cetyl palmitate 2.0
(11) Sorbitan sesquioleate 0.5
(12) Polyoxyethylene monooleate (20E.O.)
Sorbitan 1.5
(13) Preservative appropriate amount (14) Triethanolamine 1.2
(15) 1,3-butylene glycol 8.0
(16) Glycerin 2.0
(17) Polyethylene glycol 20000 0.5
(18) Purified water remaining amount (19) 1% aqueous solution of carboxyvinyl polymer 5.0
(20) Hilaragiku extract * 2 1.0
(21) Fragrance appropriate amount * 1: Cosmol 168AR (Nisshin Oillio Group)
* 2 Extract prepared in Example 1
調製したクリームは、コクのあるなめらかな使用感があり、肌のエモリエント感に優れ、キメを整え、つややはり、弾力のある美しい肌にすることができるクリームであった。 The prepared cream was a cream that had a smooth and smooth feeling of use, excellent skin emollient, smoothed texture, and, after all, made beautiful skin with elasticity.
[例10:美容液の調製例]
以下の組成の美容液を以下の方法で調製した。
(製法)
A.下記成分(1)〜(8)を混合溶解する。
B.下記成分(9)〜(17)を混合溶解する。
C.BにAを加え混合し、美容液を得た。
(成分) %
(1)トリ2−エチルヘキサン酸グリセリル 0.1
(2)メドウホーム油 0.05
(3)ホホバ油 0.05
(4)防腐剤 適量
(5)香料 適量
(6)モノオレイン酸ポリオキシエチレン(20E.O.)
ソルビタン 0.5
(7)イソステアリン酸ポリオキシエチレン硬化
ヒマシ油(50E.O.) 1.5
(8)エチルアルコール 5.0
(9)グリセリン 4.0
(10)ジプロピレングリコール 8.0
(11)1,3−ブチレングリコール 8.0
(12)乳酸ナトリウム 0.5
(13)ピロリドンカルボン酸ナトリウム(50%)液 0.5
(14)ヒドロキシエチルセルロース 0.08
(15)アルギン酸ナトリウム 0.05
(16)ヒヒラギギク抽出液*1 0.1
(17)精製水 残量
*1 例1で調製した抽出液
[Example 10: Preparation example of cosmetic liquid]
A serum having the following composition was prepared by the following method.
(Manufacturing method)
A. The following components (1) to (8) are mixed and dissolved.
B. The following components (9) to (17) are mixed and dissolved.
C. A was added to B and mixed to obtain a serum.
(Ingredient)%
(1) Glyceryl tri-2-ethylhexanoate 0.1
(2) Meadow Home Oil 0.05
(3) Jojoba oil 0.05
(4) Preservative appropriate amount (5) perfume appropriate amount (6) polyoxyethylene monooleate (20E.O.)
Sorbitan 0.5
(7) Polyoxyethylene hydrogenated isostearate castor oil (50 EO) 1.5
(8) Ethyl alcohol 5.0
(9) Glycerin 4.0
(10) Dipropylene glycol 8.0
(11) 1,3-butylene glycol 8.0
(12) Sodium lactate 0.5
(13) Sodium pyrrolidonecarboxylate (50%) solution 0.5
(14) Hydroxyethyl cellulose 0.08
(15) Sodium alginate 0.05
(16) Hilaragiku extract * 1 0.1
(17) Purified water remaining * 1 Extract prepared in Example 1
調製した美容液は、みずみずしくもなめらかでマイルドな使用感があり、肌のうるおいやエモリエント感に優れ、キメを整え、つややはり、弾力のある美しい肌にすることができる美容液であった。 The prepared essence had a fresh, smooth and mild feel, was excellent in moisture and emollient, had a smooth texture, and was able to give glossy and beautiful skin.
[例11:パックの調製例]
以下の組成のパックを、以下の方法で調製した。
(製法)
A.下記成分(1)〜(5)を加熱溶解する。
B.下記成分(6)〜(10)を混合溶解する。
C.Aを冷却後、B及び下記(11)を加え混合し、パックを得た。
(成分) %
(1)ポリビニルアルコール 12.0
(2)メチルセルロース 0.1
(3)グリセリン 3.0
(4)1,3−ブチレングリコール 5.0
(5)精製水 残量
(6)香料 適量
(7)防腐剤 適量
(8)トリ2−エチルヘキサン酸グリセリル 0.1
(9)モノオレイン酸ポリオキシエチレン(20E.O.)
ソルビタン 1.0
(10)エチルアルコール 13.0
(11)ヒヒラギギク抽出液*1 0.1
*1 例1で調製した抽出液
[Example 11: Preparation example of pack]
A pack having the following composition was prepared by the following method.
(Manufacturing method)
A. The following components (1) to (5) are dissolved by heating.
B. The following components (6) to (10) are mixed and dissolved.
C. After cooling A, B and the following (11) were added and mixed to obtain a pack.
(Ingredient)%
(1) Polyvinyl alcohol 12.0
(2) Methylcellulose 0.1
(3) Glycerin 3.0
(4) 1,3-butylene glycol 5.0
(5) Purified water remaining amount (6) perfume appropriate amount (7) preservative appropriate amount (8) glyceryl tri-2-ethylhexanoate 0.1
(9) Polyoxyethylene monooleate (20E.O.)
Sorbitan 1.0
(10) Ethyl alcohol 13.0
(11) Hilaragiku extract * 1 0.1
* 1 Extract prepared in Example 1
調製したパックは、伸びひろがりがよく、肌に適度な緊張感を付与し、パックを剥がした後の肌にはべたつきはなく、高い潤いとはりがでるパックであった。 The prepared pack was a pack that stretched well, imparted moderate tension to the skin, did not stick to the skin after peeling off the pack, and was highly moist and sticky.
[例12:マッサージクリームの調製例]
以下の組成のマッサージクリームを、以下の方法で調製した。
(製法)
A.下記成分(1)〜(9)を加熱溶解し、70℃に保つ。
B.下記成分(10)〜(13)を加熱溶解し、70℃に保つ。
C.BにAを加え乳化する。
D.Cを冷却後、下記成分(14)及び(15)を加え混合し、マッサージクリームを得た。
(成分) %
(1)ステアリン酸 2.0
(2)ステアリルアルコール 2.5
(3)親油型モノステアリン酸グリセリン 2.0
(4)セスキオレイン酸ソルビタン 1.0
(5)パルミチン酸セチル 1.0
(6)ジペンタエリトリット脂肪酸エステル*1 4.0
(7)ワセリン 20.0
(8)流動パラフィン 28.0
(9)メチルポリシロキサン(100CS) 0.5
(10)水酸化ナトリウム 0.1
(11)ジプロピレングリコール 7.0
(12)カルボキシビニルポリマー1%溶液 5.0
(13)精製水 残量
(14)ヒヒラギギク抽出液*2 0.2
(15)香料 適量
*1:コスモール168AR(日清オイリオグループ社製)
*2:例1で調製した抽出液
[Example 12: Preparation example of massage cream]
A massage cream having the following composition was prepared by the following method.
(Manufacturing method)
A. The following components (1) to (9) are dissolved by heating and maintained at 70 ° C.
B. The following components (10) to (13) are dissolved by heating and maintained at 70 ° C.
C. A is added to B and emulsified.
D. After cooling C, the following components (14) and (15) were added and mixed to obtain a massage cream.
(Ingredient)%
(1) Stearic acid 2.0
(2) Stearyl alcohol 2.5
(3) Lipophilic glyceryl monostearate 2.0
(4) Sorbitan sesquioleate 1.0
(5) Cetyl palmitate 1.0
(6) Dipentaerythritol fatty acid ester * 1 4.0
(7) Vaseline 20.0
(8) Liquid paraffin 28.0
(9) Methyl polysiloxane (100CS) 0.5
(10) Sodium hydroxide 0.1
(11) Dipropylene glycol 7.0
(12) 1% solution of carboxyvinyl polymer 5.0
(13) Purified water Remaining amount (14) Hilaragiku extract * 2 0.2
(15) Fragrance appropriate amount * 1: Cosmol 168AR (Nisshin Oillio Group)
* 2: Extract prepared in Example 1
調製したマッサージクリームは、なめらかでコクのある使用感があり、マッサージ効果に優れ、肌のたるみやはり、弾力性の低下を防ぐ効果の高いマッサージクリームであった。 The prepared massage cream had a smooth and rich feeling of use, had an excellent massage effect, and was highly effective in preventing sagging of the skin and the decrease in elasticity.
[例13:クリームファンデーションの調製例]
以下の組成のクリームファンデーションを、以下の方法で調製した。
(製法)
A:下記成分(8)〜(13)を混合する。
B:下記成分(14)〜(19)を混合する。
C:Aに下記成分(1)〜(7)を添加し混合分散する。
D:Cに下記成分(20)及び(21)を加えクリームファンデーションを得た。
(成分) %
(1)セリサイト 8.0
(2)酸化チタン 10.0
(3)ベンガラ 1.0
(4)黄色酸化鉄 2.2
(5)雲母チタン 2.0
(6)黒酸化鉄 0.1
(7)有機変成ベントナイト*1 0.5
(8)長鎖アルキル含有ポリオキシアルキレン変性
オルガノポリシロキサン*2 2.0
(9)ポリオキシアルキレン変性オルガノポリシロキサン*3 2.0
(10)デカメチルシクロペンタシロキサン 12.0
(11)オクタメチルシクロテトラシロキサン 10.0
(12)トリメチルシロキシケイ酸のシリコーン溶液*4 3.0
(13)トリ2−エチルヘキサン酸グリセリル 5.0
(14)1,3−ブチレングリコール 5.0
(15)ジグリセリン 2.0
(16)グリセリン 2.0
(17)キサンタンガム 0.2
(18)塩化ナトリウム 0.2
(19)精製水 残量
(20)ヒヒラギギク抽出液*5 0.1
(21)香料 適量
*1:ベントン38(NLエンダストリー社製)
*2:アビルEM−90(ゴールドシュミット社製)
*3:KF−6017(信越化学工業社製)
*4:KF−7312J(信越化学工業社製)
*5:例1で調製した抽出液
[Example 13: Preparation example of cream foundation]
A cream foundation having the following composition was prepared by the following method.
(Manufacturing method)
A: The following components (8) to (13) are mixed.
B: The following components (14) to (19) are mixed.
C: The following components (1) to (7) are added to A and mixed and dispersed.
D: The following components (20) and (21) were added to C to obtain a cream foundation.
(Ingredient)%
(1) Sericite 8.0
(2) Titanium oxide 10.0
(3) Bengala 1.0
(4) Yellow iron oxide 2.2
(5) Mica titanium 2.0
(6) Black iron oxide 0.1
(7) Organic metamorphic bentonite * 1 0.5
(8) Long chain alkyl-containing polyoxyalkylene modified organopolysiloxane * 2 2.0
(9) Polyoxyalkylene-modified organopolysiloxane * 3 2.0
(10) Decamethylcyclopentasiloxane 12.0
(11) Octamethylcyclotetrasiloxane 10.0
(12) Trimethylsiloxysilicic acid silicone solution * 4 3.0
(13) Glyceryl tri-2-ethylhexanoate 5.0
(14) 1,3-butylene glycol 5.0
(15) Diglycerin 2.0
(16) Glycerin 2.0
(17) Xanthan gum 0.2
(18) Sodium chloride 0.2
(19) Purified water Residual amount (20) Hilaragiku extract * 5 0.1
(21) Perfume appropriate amount * 1: Benton 38 (manufactured by NL Endowry)
* 2: Avil EM-90 (Gold Schmidt)
* 3: KF-6017 (manufactured by Shin-Etsu Chemical Co., Ltd.)
* 4: KF-7312J (manufactured by Shin-Etsu Chemical Co., Ltd.)
* 5: Extract prepared in Example 1
調製したクリームファンデーションは、べたつき感のないなめらかな使用感があり、肌への付着性に優れ、美しい仕上がりとなり、また、肌にエモリエント感を付与し、つややはり、弾力のある美しい肌にすることができるクリームファンデーションであった。 The prepared cream foundation has a smooth, non-sticky feel, excellent adhesion to the skin, a beautiful finish, and gives an emollient feel to the skin to make it beautiful and elastic. It was a cream foundation.
本発明によれば、安全性が良好な、新規なコラーゲン産生促進剤及び老化防止用皮膚外用剤を提供することができる。 ADVANTAGE OF THE INVENTION According to this invention, the novel collagen production promoter and anti-aging skin external preparation with favorable safety | security can be provided.
Claims (2)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2008102314A JP2009249366A (en) | 2008-04-10 | 2008-04-10 | Collagen production promotor and anti-aging skin preparation for external use |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2008102314A JP2009249366A (en) | 2008-04-10 | 2008-04-10 | Collagen production promotor and anti-aging skin preparation for external use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JP2009249366A true JP2009249366A (en) | 2009-10-29 |
Family
ID=41310384
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008102314A Pending JP2009249366A (en) | 2008-04-10 | 2008-04-10 | Collagen production promotor and anti-aging skin preparation for external use |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2009249366A (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012111187A1 (en) | 2011-02-14 | 2012-08-23 | 株式会社J-オイルミルズ | Skin collagen production promoter |
| WO2020090321A1 (en) | 2018-10-30 | 2020-05-07 | 株式会社村田製作所 | Heat shock protein gene expression regulator, medicine, cosmetic, and method for producing heat shock protein gene expression regulator |
| WO2021059986A1 (en) | 2019-09-25 | 2021-04-01 | 株式会社村田製作所 | Collagen production enhancer, pharmaceutical, cosmetic, and method for producing collagen production enhancer |
| KR102870251B1 (en) | 2025-01-09 | 2025-10-14 | 주식회사 에이유랩스 | Cosmetic Compostion comprising Niacinaminde, Gold and Betaine as Active Ingredients, and Manufacturing Method of the Same |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH115975A (en) * | 1997-04-23 | 1999-01-12 | Sansho Seiyaku Co Ltd | Active oxygen scavenger and its use |
| JPH11106311A (en) * | 1997-07-31 | 1999-04-20 | Sansho Seiyaku Co Ltd | Hyaluronidase activity inhibitor and use thereof |
| JP2000095663A (en) * | 1998-09-24 | 2000-04-04 | Kose Corp | Agent for external use containing plant extract |
-
2008
- 2008-04-10 JP JP2008102314A patent/JP2009249366A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH115975A (en) * | 1997-04-23 | 1999-01-12 | Sansho Seiyaku Co Ltd | Active oxygen scavenger and its use |
| JPH11106311A (en) * | 1997-07-31 | 1999-04-20 | Sansho Seiyaku Co Ltd | Hyaluronidase activity inhibitor and use thereof |
| JP2000095663A (en) * | 1998-09-24 | 2000-04-04 | Kose Corp | Agent for external use containing plant extract |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012111187A1 (en) | 2011-02-14 | 2012-08-23 | 株式会社J-オイルミルズ | Skin collagen production promoter |
| US9522109B2 (en) | 2011-02-14 | 2016-12-20 | J-Oil Mills, Inc. | Skin collagen enhancing agent |
| WO2020090321A1 (en) | 2018-10-30 | 2020-05-07 | 株式会社村田製作所 | Heat shock protein gene expression regulator, medicine, cosmetic, and method for producing heat shock protein gene expression regulator |
| WO2021059986A1 (en) | 2019-09-25 | 2021-04-01 | 株式会社村田製作所 | Collagen production enhancer, pharmaceutical, cosmetic, and method for producing collagen production enhancer |
| KR102870251B1 (en) | 2025-01-09 | 2025-10-14 | 주식회사 에이유랩스 | Cosmetic Compostion comprising Niacinaminde, Gold and Betaine as Active Ingredients, and Manufacturing Method of the Same |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR101186081B1 (en) | Functional powder | |
| JP2005220084A (en) | Acerola seed extract-containing composition | |
| JP3987793B2 (en) | Topical skin preparation | |
| JP2002212087A (en) | External preparation for skin | |
| JP2003063925A (en) | External preparation for skin | |
| JP6781529B2 (en) | Skin care cosmetic composition | |
| JP2009249366A (en) | Collagen production promotor and anti-aging skin preparation for external use | |
| JP5863225B2 (en) | Skin care composition | |
| WO1999022709A1 (en) | Cosmetics and process for the preparation of extract of the nest of $i(oceanodroma sp.) | |
| JP2011195539A (en) | Elastase activity inhibitor | |
| JP2012201615A (en) | Elastase activity inhibitor | |
| JP2010150173A (en) | Skin whitening agent, melanogenesis inhibitor, and skin whitening skin external preparation | |
| JP4713032B2 (en) | Skin preparation | |
| JP2009234976A (en) | Cell activator and external preparation for skin for antiaging | |
| JP5429851B2 (en) | Active oxygen scavenger, skin external preparation and cosmetic using the active oxygen scavenger | |
| JP5313524B2 (en) | Anti-inflammatory agent and anti-inflammatory skin external preparation | |
| JP5226200B2 (en) | Sulfated glycosaminoglycan production promoter and skin external preparation containing the same | |
| JP2009249365A (en) | Cell activator and anti-aging skin preparation for external use | |
| JP3746260B2 (en) | Topical skin preparation | |
| JP6170314B2 (en) | Antioxidants with fu extract | |
| JP2009256326A (en) | Skin whitening preparation, and skincare preparation | |
| JP2009298728A (en) | Cell activator and external preparation for skin for preventing senescence | |
| JP2003321377A (en) | Antioxidant and skin care preparation obtained using the same | |
| KR20160017891A (en) | Composition for protecting skin with antioxidant activity comprising egf and placenta | |
| JP5275779B2 (en) | Whitening agent and external preparation for skin |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20110126 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20120516 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20120619 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20120808 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20130319 |
